3 completed, 1 recruiting. 2 Phase 4, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Recruiting 1 |
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Primary Sjogren Syndrome: new trials by email Literature Review of Primary Sjogren Syndrome trials Research Report on Primary Sjogren Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TREATMENT OF VAGINAL DRYNESS IN SJÖGREN'S DISEASE WITH CO2-LASER VERSUS TOPICAL PROMESTRIENE Fractional CO2 laser (vaginal), Promestriene Vaginal - Sjogren Syndrome, Sjogren Disease | Phase 4 | Recruiting | University of Sao Paulo General Hospital | 60 | 2026-02-27 | 2026-03-03 |
| Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS) VAY736, Placebo - Primary Sjogren Syndrome | Phase 2 | Completed | Novartis Pharmaceuticals | 190 | 2017-06-27 | 2025-01-07 |
| Laser Therapy to Treat the Dry Mouth of Sjogren's Syndrome Lasertherapy, Sham Lasertherapy - KERATOCONJUNCTIVITIS SICCA, XEROSTOMIA | Not applicable | Completed | Federal University of São Paulo | 66 | 2014-05-01 | 2017-08-03 |
| Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease Restasis, Refresh Endura - Primary Sjogren Syndrome, Secondary Sjogren Syndrome | Phase 4 | Completed | Federal University of São Paulo | 100 | 2013-01-01 | 2020-09-22 |
Sjogren's Syndrome (2) · Dry Eye Syndromes (1) · Keratoconjunctivitis Sicca (1) · Xerostomia (1)
Eye Diseases (3) · Lacrimal Apparatus Diseases (3) · Arthritis (2) · Arthritis, Rheumatoid (2) · Autoimmune Diseases (2) · Connective Tissue Diseases (2) · Dry Eye Syndromes (2) · Immune System Diseases (2) · Joint Diseases (2) · Mouth Diseases (2) · Musculoskeletal Diseases (2) · Rheumatic Diseases (2) · Salivary Gland Diseases (2) · Skin and Connective Tissue Diseases (2) · Stomatognathic Diseases (2)
Castor Oil (1) · Cyclosporins (1) · ianalumab (1)
Federal University of São Paulo (2) · Novartis Pharmaceuticals (1) · University of Sao Paulo General Hospital (1)
Brazil (3) · Argentina (1) · Austria (1) · Belgium (1) · Chile (1) · France (1) · Germany (1) · Hungary (1) · Israel (1) · Italy (1) · Japan (1) · Netherlands (1) · Poland (1) · Portugal (1) · Romania (1)
Rossen M Hazarbassanov, PhD (1) · Virginia M Trevisani, PhD (1)